Award
NIH Reporter #5R01CA285967-02
Targeting heat shock factor 1 (HSF1) to increase tumor infiltrating lymphocytes in metastatic breast cancer.
Recipient
Not specified
Award Amount
$375,964.00
Ceiling
$375,964.00
Awarded
April 27, 2026
Identifier
5R01CA285967-02
Award for research targeting HSF1 to boost immune response in metastatic breast cancer, funded by NIH/NCI.
Description
This project involves targeting heat shock factor 1 (HSF1) to enhance immune response in metastatic breast cancer, with multiple aims including studying immune cell recruitment, evaluating HSF1 inhibition efficacy, and understanding myeloid cell roles. The funding is provided by the NIH/NCI, with a focus on immunotherapy and cancer treatment research.